Finance

Lists
Why is ONCOZ down 6,94%?
Dive Deeper
ONCOZ:STO
Oncozenge AB
SEK 3,35
-6,94%
(-0,25) 1D
15 Okt., 09:59:49 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCOZ...
Open
SEK 3,42
High
SEK 3,58
Low
SEK 3,35
Mkt. cap
88,78 m
Avg. vol.
62,70 k
Volume
12,41 k
52-wk high
SEK 8,58
52-wk low
SEK 3,10
EPS
-SEK 1,47
Shares outstanding
26,50 m
No. of employees
1
Open
SEK 3,42
High
SEK 3,58
Low
SEK 3,35
Mkt. cap
88,78 m
Avg. vol.
62,70 k
Volume
12,41 k
52-wk high
SEK 8,58
52-wk low
SEK 3,10
EPS
-SEK 1,47
Shares outstanding
26,50 m
No. of employees
1
News stories
From web sources and news partners
About Oncozenge AB
CEOPaul de Potocki
Employees1
Founded2020
Headquarters-
SectorPharmaceutical industry
Websiteoncozenge.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,00 k
1,00 k
-
5,96 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,48 m
9,75 m
6,80 m
11,25 m
Operating expense
3,48 m
9,75 m
6,80 m
11,40 m
Total operating expenses
3,48 m
9,75 m
6,80 m
11,40 m
Operating income
-3,48 m
-9,75 m
-6,80 m
-5,44 m
Other non operating income
-
-
-
-
EBT including unusual items
-3,49 m
-9,89 m
-7,13 m
-5,67 m
EBT excluding unusual items
-3,49 m
-9,89 m
-7,13 m
-5,67 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2,00 k
-
2,00 k
150,00 k
Net income
-3,49 m
-9,89 m
-7,13 m
-5,67 m
Net profit margin
-174 550,00%
-988 600,00%
-
-95,04%
Earnings per share
-
-
-
-
Interest and investment income
1,00 k
15,00 k
-
-
Interest expense
-13,00 k
-154,00 k
-330,00 k
-226,00 k
Net interest expenses
-12,00 k
-139,00 k
-330,00 k
-226,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme